Philly Judge OKs Investors' $4M CBD Study Settlement Deal
A federal judge in Philadelphia has given an initial nod to a $4 million settlement agreement that would end investor claims that the CBD drugmaker Zynerba Pharmaceuticals Inc. withheld adverse details...To view the full article, register now.
Already a subscriber? Click here to view full article